ABBOTT LABORATORIES — Director's Dealing 2016

Jul 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-07-25

Reporting Person: Funck Robert E (Vice President, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-25	Common shares without par value	M	26800	$25.2461	Acquired	111819	Direct
2016-07-25	Common shares without par value	S	26800	$43.08	Disposed	85019	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-25	Option (right to buy)	$25.2461	M	26800	Disposed	2017-02-15	Common shares (26800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	16353	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 25, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.